CrestPoint Capital Management’s Johnson & Johnson JNJ Stock Holding History

CrestPoint Capital Management’s Portfolio JNJ Stock Details JNJ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$3.12M	Sell	22,300 -7,700	-26%	-$1.07M	1.73%	7
2017 Q3	$3.9M	Sell	30,000 -300	-1%	-$39.8K	1.74%	7
2017 Q2	$4.01M	Sell	30,300 -800	-3%	-$102K	1.88%	5
2017 Q1	$3.87M	Sell	31,100 -700	-2%	-$83.6K	1.85%	4
2016 Q4	$3.66M	Buy	31,800 +1,200	+4%	+$139K	1.84%	5
2016 Q3	$3.62M	Sell	30,600 -1,200	-4%	-$146K	1.85%	5
2016 Q2	$3.86M	Hold	31,800	–	–	2.05%	2
2016 Q1	$3.44M	Buy	31,800 +800	+3%	+$82.8K	1.87%	3
2015 Q4	$3.18M	Sell	31,000 -100	-0.3%	-$10.1K	1.8%	5
2015 Q3	$2.9M	Sell	31,100 -4,200	-12%	-$406K	1.67%	7
2015 Q2	$3.44M	Buy	35,300 +300	+0.9%	+$30K	1.82%	5
2015 Q1	$3.52M	Buy	35,000 +1,700	+5%	+$173K	1.83%	4
2014 Q4	$3.48M	Buy	33,300 +1,300	+4%	+$137K	1.89%	4
2014 Q3	$3.41M	Sell	32,000 -30	-0.1%	-$3.11K	2.06%	2
2014 Q2	$3.35M	Buy	32,030 +1,000	+3%	+$101K	1.95%	2
2014 Q1	$3.05M	Sell	31,030 -1,000	-3%	-$92.7K	1.89%	1
2013 Q4	$2.93M	Buy	+32,030	New	+$2.95M	1.94%	3

Other funds holding JNJ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

CrestPoint Capital Management's JNJ Position: Q4 2017 in Review

CrestPoint Capital Management reduced its Johnson & Johnson (JNJ) stake by 26% in Q4 2017, selling an estimated $1.07M and leaving 22,300 shares worth $3.12M. The position accounts for 1.73% of the portfolio, ranked #7.

CrestPoint Capital Management first reported a position in JNJ in Q4 2013 and has held it in 17 quarters since. The position peaked at $4.01M in Q2 2017. 2,624 funds tracked by Wall St. Rank hold JNJ as of Q4 2017.

CrestPoint Capital Management held 22,300 shares of Johnson & Johnson worth $3.12M as of Q4 2017.
CrestPoint Capital Management sold 7,700 Johnson & Johnson shares in Q4 2017, an estimated $1.07M.
Johnson & Johnson made up 1.73% of CrestPoint Capital Management's portfolio in Q4 2017, its #7 holding.
CrestPoint Capital Management first reported a position in Johnson & Johnson in Q4 2013 and has held it in 17 quarters since.
CrestPoint Capital Management's Johnson & Johnson position peaked at $4.01M in Q2 2017.
2,624 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2017.

Based on CrestPoint Capital Management's 13F filing for Q4 2017, filed 17 Jan 2018.